News

A statement from the Australian Technical Advisory Group on Immunisation (ATAGI) on COVID-19 vaccination and a reported case of thrombosis.

A statement from the Australian Technical Advisory Group on Immunisation (ATAGI) for consumers on a specific clotting condition being reported after COVID-19 vaccination

Influenza vaccines through the National Immunisation Program (NIP) became available in April 2021. Timing may be different for your local area. You can order vaccines through the usual channels in your state or territory.

Vaccination against influenza (flu) remains important this year. Flu is a highly contagious viral infection that can cause widespread illness and deaths every year. Vaccination is our best defence against flu viruses.

The Australian Public Service employee census report for 2020 has been released. Read more about the census and Health's results.

The floods affecting New South Wales and Queensland can also impact our health in many ways. Learn more on how you can access medical help you need, and what the Australian Government is doing to support your health during this time.

The Australian Government is providing $3.2 million for the fourth and final round of the $45 million BioMed Tech Horizons program. This program has been successful in bringing cutting edge medical devices to market.

A statement from the Australian Technical Advisory Group on Immunisation (ATAGI) for health care providers on suitability of COVID-19 vaccination in people with history of clotting conditions.

The Australian Government is providing $2.6 million for the latest information technology to improve the lives of people who have survived brain cancer.

This statement from the Australian Technical Advisory Group on Immunisation (ATAGI) updates advice previous provided on 16 March. It follows the European Medicines Agency (EMA) safety review of the AstraZeneca COVID-19 vaccine.

Vaccination against influenza remains important this year. Vaccination experts recommend influenza vaccination for all people aged 6 months and over. The National Immunisation Program (NIP) funds influenza vaccines for people most at risk.

COVID-19 vaccination appointments will be available at GP-led respiratory clinics from 19 March 2021. Find out more.

The Australian Government has announced a $15 million competitive grant round to kick start clinical trials exploring the use of combination therapies to treat mental illnesses.

A new Medical Research Future Fund (MRFF) grant opportunity is supporting Australian researchers to lead, and participate in, international collaborative clinical trials.

Australians eligible for Phase 1b will be able to find a vaccination provider through the new national vaccination information and location service.

A statement from the Australian Technical Advisory Group on Immunisation (ATAGI) regarding overnight decisions in Europe suspending the use of the AstraZeneca vaccine.

Important life choices are planned, not left to chance. Find out what you can do today to ensure more control over your health care choices into the future. Whether it’s for you or someone you love, get involved in National Advance Care Planning Week from 22–26 March 2021.

Nominations for the Electrocardiogram (ECG) Review Committee have now closed. Nominations are currently being reviewed and nominees will be notified of the outcome of their nomination as soon as possible.

A presentation about Australia's COVID-19 vaccine rollout is now available to view or download.

The Prime Minister has announced the Government will invest more than $1.1 billion to extend Australia's national COVID-19 health response and suppression strategy. Find out more.

Is it true? is a new feature on our website to help answer questions people may have about COVID-19 vaccines and respond to vaccine misinformation they may have heard. Find out more.

Public consultation on the draft Strategy is open until 19 April 2021. The Strategy aims to improve the health of all Australians at all stages of life.

Read the Prime Minister’s update following the National Cabinet meeting on 5 March 2021.

The Australian Technical Advisory Group on Immunisation has provided advice to support immunisation providers ahead of this year’s influenza season.

The Australian Government has listed a range of medicines for treating multiple sclerosis, asthma and diabetes on the Pharmaceutical Benefits Scheme (PBS). The listings will provide valuable support for more than 51,800 Australians living with these conditions, saving them up to $29,000 a year.